These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 7216489)
1. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate. Yarkoni E; Lederer E; Rapp HJ Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489 [TBL] [Abstract][Full Text] [Related]
2. Regression of tumors in guinea pigs after treatment with synthetic muramyl dipeptides and trehalose dimycolate. McLaughlin CA; Schwartzman SM; Horner BL; Jones GH; Moffatt JG; Nestor JJ; Tegg D Science; 1980 Apr; 208(4442):415-6. PubMed ID: 7189295 [TBL] [Abstract][Full Text] [Related]
3. Comparison of muramyl dipeptide, trehalose dimycolate, and dimethyl dioctadecyl ammonium bromide as adjuvants in Brucella abortus 45/20 vaccines. Woodard LF; Toone NM; McLaughlin CA Infect Immun; 1980 Nov; 30(2):409-12. PubMed ID: 6777304 [TBL] [Abstract][Full Text] [Related]
4. Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets. Masihi KN; Lange W; Rohde-Schulz B Cancer Immunol Immunother; 1987; 24(1):19-24. PubMed ID: 3815418 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of endotoxic shock by N-acetylmuramyl-L-alanyl-(L-seryl)-D-isoglutamine (muramyl dipeptide). Ribi EE; Cantrell JL; Von Eschen KB; Schwartzman SM Cancer Res; 1979 Nov; 39(11):4756-9. PubMed ID: 115579 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate. Masihi KN; Brehmer W; Azuma I; Lange W; Müller S Infect Immun; 1984 Jan; 43(1):233-7. PubMed ID: 6317568 [TBL] [Abstract][Full Text] [Related]
7. Brucella abortus vaccines: comparison of protection provided by immunopotentiated 45/20 bacterins and live strain 19 vaccine in guinea pigs. Woodard LF; Toone NM; Jasman RL Am J Vet Res; 1981 Nov; 42(11):1959-62. PubMed ID: 6802042 [TBL] [Abstract][Full Text] [Related]
8. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil. Yarkoni E; Rapp HJ Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795 [TBL] [Abstract][Full Text] [Related]
9. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs. Yarkoni E; Rapp HJ Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325 [TBL] [Abstract][Full Text] [Related]
10. Regression of line-10 hepatocarcinoma with synthetic quinonyl muramyl dipeptide in strain-2 guinea pigs. Tanio Y; Souma H; Tokushima Y; Yamamura Y; Azuma I Gan; 1983 Apr; 74(2):192-5. PubMed ID: 6862142 [TBL] [Abstract][Full Text] [Related]
11. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil. Carelli C; Audibert F; Chedid L Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069 [TBL] [Abstract][Full Text] [Related]
12. Antitumor activity on line 10 hepatoma in strain 2 guinea pigs and pharmaceutical properties of quinonyl-MDP preparations. Azuma I; Ogawa Y; Igari Y; Ukei S; Yamamura Y Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):15-8. PubMed ID: 3702541 [TBL] [Abstract][Full Text] [Related]
13. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin. Bloksma N; Hofhuis FM; Willers JM Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290 [TBL] [Abstract][Full Text] [Related]
14. Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP). Tanaka A; Emori K Am J Pathol; 1980 Mar; 98(3):733-48. PubMed ID: 6767407 [TBL] [Abstract][Full Text] [Related]
15. Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition. Kohashi O; Tanaka A; Kotani S; Shiba T; Kusumoto S; Yokogawa K; Kawata S; Ozawa A Infect Immun; 1980 Jul; 29(1):70-5. PubMed ID: 7399708 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic properties of soluble antigens or whole cells of Brucella abortus strain 45/20 associated with immunoadjuvants. II. Whole cells. Woodard LF; Toone NM; McLaughlin CA Can J Comp Med; 1980 Oct; 44(4):456-8. PubMed ID: 6778600 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy with an intralesionally administered synthetic cord factor analogue. Yarkoni E; Rapp HJ; Polonsky J; Lederer E Int J Cancer; 1978 Nov; 22(5):564-9. PubMed ID: 721317 [TBL] [Abstract][Full Text] [Related]
18. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
19. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration. Yarkoni E; Meltzer MS; Rapp HJ Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative. Phillips NC; Tsao MS Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]